AEGiS-ST: Prisoners still denied ARV drugs Sunday Times (Johannesburg)Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to Sunday Times (Johannesburg) main menu
DonateNow
Print this article

Prisoners still denied ARV drugs

Sunday Times (Johannesburg) - June 8, 2007
Monica Laganparsad


The Department of Correctional Services is likely to be tied up in litigation yet again if it continues to ignore prisoners' calls for access to antiretroviral drugs for the treatment of HIV/Aids.

The Aids Law Project revealed its plans for the treatment of HIV-positive prisoners yesterday at an Aids conference in Durban.

The project, the prisons authorities and the department of health have been embroiled in a heated court battle since last year over the provision of ARV treatment for prisoners at Westville Prison.

An application for a court order that would compel the prisons department to provide ARV treatments was made on behalf of 15 prisoners, three of whom have since died.

Judge Thumba Pillay agreed that the health minister and the Department of Correctional Services must provide ARVs for infected prisoners .

He ordered the department to set out in detail how it would deal with the treatment of HIV- positive prisoners.

But the Aids Law Project said yesterday that though it had been agreed that a treatment plan would be implemented at prisons around the country, nothing had been done.

Jonathan Berger, a senior researcher for the project, said the project had been given the go-ahead by the government but, two weeks before the matter was due to go back to court, officials denied that an agreement had been reached.

He said the planned treatment framework would deal with access , regular testing and nutrition.

Berger said some prisoners at the Westville facility did not have access to condoms.


070608
ST070604


Copyright © 2007 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .